Palisade Bio, Inc. (PALI)
NASDAQ·Healthcare·Biotechnology
$1.62
-4.73%
Mkt Cap $275.99M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$4.50
Range $2.00 – $7.00
Implied Upside
+177.8%
Consensus $4.50 vs current $1.62
NASDAQ·Healthcare·Biotechnology
$1.62
-4.73%
Mkt Cap $275.99M
No recent rating data.
Price Target (3 analysts)
$4.50
Range $2.00 – $7.00
+177.8%
Consensus $4.50 vs current $1.62